Procept BioRobotics appoints cardiac surgeon Michael Mack to board

PRCT•2026-10-02

Procept BioRobotics expanded its board to 10 directors on Oct. 2, 2026, appointing cardiac surgeon Michael Mack to a new seat with a term through the 2029 annual stockholder meeting.

Procept BioRobotics appoints cardiac surgeon Michael Mack to board

1. Board appointment

Related News

H&R Block Chief Retail Officer Mark J. Darling sells 2,700 shares for $109,852.74

Gilead CEO Daniel O’Day disposes of $2,216,507.50 in common shares

AbbVie joins US government pilot to test drug discount rebates

Sources

Procept BioRobotics appoints cardiac surgeon Michael Mack to board

Ares Strategic Income Fund says Cox Capital Partners offers $23.15 per share in mini-tender

Iovance Biotherapeutics files Form 3 for CMO Noah Berkowitz